+958.0%
MRNA vs ARES
+664.3%
+293.7%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | ARES | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | +0.2% | -5.0% | -4.9% |
| 7D | -20.9% | -7.2% | -13.7% | -18.7% |
| 30D | -13.3% | +13.3% | -26.5% | -17.1% |
| 3M | +212.6% | -7.8% | +220.4% | +223.4% |
| 6M | +309.0% | +5.6% | +303.4% | +302.4% |
| YTD | +567.3% | -18.1% | +585.4% | +603.0% |
| 1Y | +689.7% | -6.6% | +696.3% | +696.5% |
| 3Y | +157.4% | +31.2% | +126.2% | +130.0% |
| 5Y | -21.7% | +69.2% | -90.9% | -38.5% |
| All | +958.0% | +664.3% | +293.7% | +467.1% |
Cumulative growth
Daily Returns
Daily percentage return beside ARES.
Daily Out/Under-Performance
Portfolio return minus ARES return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ARES return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded ARES wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling